» Articles » PMID: 23543153

Morphological Classification of the Myelodysplastic Syndromes: How Much More Education of Diagnosticians is Necessary?

Overview
Journal Haematologica
Specialty Hematology
Date 2013 Apr 2
PMID 23543153
Citations 5
Authors
Affiliations
Soon will be listed here.
Citing Articles

Distinct mutation features and its clinical significance in myelodysplastic syndromes with normal karyotype.

Huang N, Chang C, Wu L, He Q, Zhang Z, Li X Ann Hematol. 2024; 103(11):4485-4495.

PMID: 39302466 DOI: 10.1007/s00277-024-06005-2.


Cytomorphology review of 100 newly diagnosed lower-risk MDS patients in the European LeukemiaNet MDS (EUMDS) registry reveals a high inter-observer concordance.

de Swart L, Smith A, MacKenzie M, Symeonidis A, Neukirchen J, Mikulenkova D Ann Hematol. 2017; 96(7):1105-1112.

PMID: 28526957 PMC: 5486793. DOI: 10.1007/s00277-017-3009-7.


Proposal of criteria for dyserythropoiesis in the diagnosis of myelodysplastic syndromes.

Kawai N, Matsuda A, Jinnai I, Ichimura T, Kayano H, Okamura D Int J Hematol. 2015; 103(2):227-33.

PMID: 26608365 DOI: 10.1007/s12185-015-1916-8.


Importance of classical morphology in the diagnosis of myelodysplastic syndrome.

Invernizzi R, Quaglia F, Della Porta M Mediterr J Hematol Infect Dis. 2015; 7(1):e2015035.

PMID: 25960863 PMC: 4418392. DOI: 10.4084/MJHID.2015.035.


Inter-observer agreement in myelodysplastic syndromes.

Ramos F, Fernandez-Ferrero S Haematologica. 2013; 98(7):e77.

PMID: 23813651 PMC: 3696598. DOI: 10.3324/haematol.2013.91231.

References
1.
Zini G, Bain B, Bettelheim P, Cortez J, dOnofrio G, Faber E . A European consensus report on blood cell identification: terminology utilized and morphological diagnosis concordance among 28 experts from 17 countries within the European LeukemiaNet network WP10, on behalf of the ELN Morphology Faculty. Br J Haematol. 2010; 151(4):359-64. DOI: 10.1111/j.1365-2141.2010.08366.x. View

2.
Vardiman J, Lee Harris N, Brunning R . The World Health Organization (WHO) classification of the myeloid neoplasms. Blood. 2002; 100(7):2292-302. DOI: 10.1182/blood-2002-04-1199. View

3.
Germing U, Strupp C, Kuendgen A, Isa S, Knipp S, Hildebrandt B . Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes. Haematologica. 2006; 91(12):1596-604. View

4.
Greenberg P, Tuechler H, Schanz J, Sanz G, Garcia-Manero G, Sole F . Revised international prognostic scoring system for myelodysplastic syndromes. Blood. 2012; 120(12):2454-65. PMC: 4425443. DOI: 10.1182/blood-2012-03-420489. View

5.
Senent L, Arenillas L, Luno E, Ruiz J, Sanz G, Florensa L . Reproducibility of the World Health Organization 2008 criteria for myelodysplastic syndromes. Haematologica. 2012; 98(4):568-75. PMC: 3659988. DOI: 10.3324/haematol.2012.071449. View